Overview

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The objective of this historical-controlled trial is to demonstrate the efficacy and safety of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are withdrawn from 1 to 2 marketed antiepileptic drugs.
Phase:
Phase 3
Details
Lead Sponsor:
UCB BIOSCIENCES, Inc.
Treatments:
Lacosamide